By: Desk Explained | Pune | Updated: September 13, 2020 8:53:31 am A healthcare worker holds blood samples during clinical trials for a Covid-19 vaccine at the Research Centers of America in Hollywood, Florida. (Photographer: Eva Marie Uzcategui / Bloomberg) Coronavirus Vaccine Tracker (COVID-19): The clinical trials of a coronavirus …
Read More »
Oxford University resumed testing the coronavirus vaccine in the United States on Saturday following confirmation by the Medicines Health Regulatory Authority (MHRA). The advanced COVID-19 vaccine trial developed by the University of Oxford and Astrazeneca was suspended this week after illness in a study subject in Britain. Here is the …
Read More »
After pharmaceutical company AstraZeneca announced the resumption of its Covid-19 vaccine trial in the UK, its partner at India Serum Institute said it will also restart trials once the General Medicines Controller of India (DGCI) gives its okay. The DGCI previously sent a show of cause notice to the Pune-based …
Read More »
After Astrazeneca resumed testing of the Oxford University coronavirus vaccine in the UK, the Serum Institute of India said on Saturday it will restart the trial in the country once allowed by the main drug regulator. Commenting on the resumption of the trial, Adar Poonawalla, executive director of the Serum …
Read More »
British-Swedish firm Astrazeneca said it had resumed testing of the coronavirus vaccine from the University of Oxford in the UK following confirmation from the Medicines Health Regulatory Authority (MHRA). The advanced COVID-19 vaccine trial developed by the University of Oxford and Astrazeneca was suspended this week after illness in a …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: September 11, 2020 7:29:25 am Covid-19 testing in New Delhi. IBS Sponsors Mid- and Late-Stage Human Clinical Trials for Candidate Vaccine in India Serum Institute of India has decided to stop the ongoing clinical trials in India of the Covid-19 candidate …
Read More »
The Serum Institute of India said on Thursday it was halting the University of Oxford-Astrazeneca’s COVID-19 vaccine trial in India until the British-Swedish drugmaker restarts the trial. The move came a day after the Pune-based vaccine maker received a notice of demonstration cause from the Drugs General Inspector of India …
Read More »
The Serum Institute of India (SII) said on Wednesday that the drugmaker will follow instructions from the central drug regulator on suspending the Oxford-AstraZeneca COVID-19 vaccine trial in India. The Controller General of Drugs of India (DCGI) issued a notice of demonstrative cause to the Serum Institute of India on …
Read More »
Written by Abhishek De | New Delhi | Updated: September 7, 2020 9:27:45 pm According to the World Health Organization, about 175 vaccine candidates are in preclinical or clinical trials today. While Russia and China may have stolen a march in the race to develop a Covid-19 vaccine, grant regulatory …
Read More »
By: Desk Explained | Pune | Updated: September 7, 2020 8:41:47 am A nurse holds China’s Sinovac vaccine, a possible vaccine for the coronavirus disease (COVID-19), at the Sao Lucas Hospital in Brazil (Reuters / Archive) Coronavirus Vaccine Tracker (COVID-19): A coronavirus vaccine being developed by a Chinese company was …
Read More »